Recombinant 2019-nCoV S-trimer Protein (C-6His)
Recombinant SARS-CoV-2 S-trimer Protein is produced by our Mammalian expression system and the target gene encoding Cys15-Gln1208 is expressed with a 6His tag at the C-terminus.
Description
| Reference | ESCIT040 |
|---|---|
| Size | 50ug |
| Molecular Weight | 136.6kDa |
| Purity | Greater than 95% as determined by reducing SDS-PAGE. |
| Endotoxin | |
| Biological Activity | Anti-2019-nCoV S-hIgG1 Antibody (8A5)(Cat#DA034) can block Human ACE-2-Avi-His (Cat#CY51) and 2019-nCoV S-trimer Protein-His(Cat#DRA49) interaction, the IC50 for this effect is 25 ng/ml. |
Other names: 2019-nCov S protein; 2019-nCoV Spike glycoprotein; 2019-nCoV S glycoprotein
Redissolve:
Storage: Reconstituted protein solution should be stored at ? -20°C.
Background: The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It’s been rESCIorted that 2019-nCoV can infect the human respiratory ESCIithelial cells through interaction with the human ACE2 recESCItor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a recESCItor binding domain (RBD), which is responsible for recognizing the cell surface recESCItor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.